Oct. 13 (Fri.) ,2017 10:00-11:00

Annex Hall
F203

【S-11】 Manufacturing Technology Association of Biologics

Made in Japan platform technology for therapeutic antibody manufacturing –Perspective for Project MAB

Therapeutic antibodies are now the workhorse for pharmaceutical industry in 21 century. From FY2013, the Manufacturing Technology Association of Biologics (MAB) started for the development of therapeutic antibody production. In this presentation, I would like to summarize and discuss the next-generation technologies and platform for therapeutic antibody production. (48words)

Made in Japan platform technology for therapeutic antibody manufacturing –Perspective for Project MAB

Takeshi Omasa

Project Leader, Manufacturing Technology Association of Biologics Professor, Graduate School of Engineering, Osaka University Visiting Professor, Tokushima University Visiting Professor, Kobe University

Close Window